Nerve Growth Factor Regulates Liver Cancer Cell Polarity and Motility

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2021 Mar 2

PMID 33649819

Citations 13

Authors

Haihua Lin

Huanjun Huang

Yuhong Yu

Weibin Chen

Shaomin Zhang

Yuanzhi Zhang

Affiliations

Soon will be listed here.

Abstract

Nerve growth factor (NGF), a prototypical neurotrophic factor essential for neuronal cell proliferation and survival, has been implicated as a marker of tumor progression, as well as a potential target for novel therapeutic approaches in cancer. To investigate the functional potential of NGF in liver cancer in the present study, a stable NGF‑overexpressing HepG2 cell line was generated. The scratch‑wound assay was used to investigate cell motility and polarity. Western blotting was performed to evaluate the expression levels of epithelial‑mesenchymal transition (EMT)‑related proteins, including E‑cadherin, N‑cadherin and vimentin. Moreover, immunofluorescence was performed to investigate the arrangement of the actin cytoskeleton. Cell anoikis resistance was examined using a suspension culture model and cell apoptosis was examined via flow cytometry. The present results indicated that NGF overexpression in HepG2 cells disrupted HepG2 cell polarity and promoted cell motility. Furthermore, NGF overexpression induced EMT and actin cytoskeleton rearrangement in HepG2 cells, as well as enhanced anoikis resistance and prevented cellular apoptosis. Notably, a tropomyosin receptor kinase A receptor inhibitor blocked NGF‑induced cell motility and apoptosis. Therefore, it was suggested that NGF serves a critical role in the invasion and metastasis of liver cancer. The use of NGF as a biomarker or potential new target could lead to the development of novel factors for diagnosis or for improving therapeutic strategies in liver cancer.

Citing Articles

Targeting nerve growth factor for pain relief: pros and cons.

Jaffal S, Khalil R Korean J Pain. 2024; 37(4):288-298.

PMID: 39322310 PMC: 11450303. DOI: 10.3344/kjp.24235.

Nerve Growth Factor and the Role of Inflammation in Tumor Development.

Ferraguti G, Terracina S, Tarani L, Fanfarillo F, Allushi S, Caronti B Curr Issues Mol Biol. 2024; 46(2):965-989.

PMID: 38392180 PMC: 10888178. DOI: 10.3390/cimb46020062.

Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma.

Gulati R, Lutz M, Hanlon M, Cast A, Karns R, Geller J Hepatol Commun. 2024; 8(2).

PMID: 38285876 PMC: 10830083. DOI: 10.1097/HC9.0000000000000369.

A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression.

Su X, Wang B, Zhou Z, Li Z, Tong S, Chen S Korean J Pain. 2022; 36(1):60-71.

PMID: 36536517 PMC: 9812689. DOI: 10.3344/kjp.22277.

A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer.

Han S, Wang D, Huang Y, Zeng Z, Xu P, Xiong H J Exp Clin Cancer Res. 2022; 41(1):348.

PMID: 36522730 PMC: 9753336. DOI: 10.1186/s13046-022-02556-2.

References

Luo T, Zhang S, Zhu L, Zhang F, Li W, Zhao K . A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019; 38(1):130. PMC: 6421704. DOI: 10.1186/s13046-019-1104-4. View

Tokusashi Y, Asai K, Tamakawa S, Yamamoto M, Yoshie M, Yaginuma Y . Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer. 2004; 114(1):39-45. DOI: 10.1002/ijc.20685. View

Zhou X, Hao Q, Liao P, Luo S, Zhang M, Hu G . Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator. Elife. 2016; 5. PMC: 4943851. DOI: 10.7554/eLife.15099. View

Blondy S, Christou N, David V, Verdier M, Jauberteau M, Mathonnet M . Neurotrophins and their involvement in digestive cancers. Cell Death Dis. 2019; 10(2):123. PMC: 6370832. DOI: 10.1038/s41419-019-1385-8. View

Royer C, Lu X . Epithelial cell polarity: a major gatekeeper against cancer?. Cell Death Differ. 2011; 18(9):1470-7. PMC: 3178423. DOI: 10.1038/cdd.2011.60. View

Frisch S, Francis H . Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994; 124(4):619-26. PMC: 2119917. DOI: 10.1083/jcb.124.4.619. View

Woodham E, Machesky L . Polarised cell migration: intrinsic and extrinsic drivers. Curr Opin Cell Biol. 2014; 30:25-32. DOI: 10.1016/j.ceb.2014.05.006. View

Kishibe K, Yamada Y, Ogawa K . Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice. Gastroenterology. 2002; 122(7):1978-86. DOI: 10.1053/gast.2002.33581. View

Olson M, Sahai E . The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis. 2008; 26(4):273-87. DOI: 10.1007/s10585-008-9174-2. View

10.

Demir I, Tieftrunk E, Schorn S, Friess H, Ceyhan G . Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochim Biophys Acta. 2016; 1866(1):37-50. DOI: 10.1016/j.bbcan.2016.05.003. View

11.

Yoon S, Carter B, Chao M . Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci. 1998; 18(9):3273-81. PMC: 6792655. View

12.

Tsai M, Lee P, Sun C, Chiu T, Lin Y, Chang I . Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target. Exp Mol Med. 2018; 50(1):e426. PMC: 5799797. DOI: 10.1038/emm.2017.235. View

13.

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

14.

Fuertes-Alvarez S, Maeso-Alonso L, Villoch-Fernandez J, Wildung M, Martin-Lopez M, Marshall C . p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton. Cell Death Dis. 2018; 9(12):1183. PMC: 6281643. DOI: 10.1038/s41419-018-1205-6. View

15.

Faulkner S, Griffin N, Rowe C, Jobling P, Lombard J, Oliveira S . Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma. FASEB Bioadv. 2020; 2(7):398-408. PMC: 7354692. DOI: 10.1096/fba.2020-00016. View

16.

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

17.

West N, McCuaig S, Franchini F, Powrie F . Emerging cytokine networks in colorectal cancer. Nat Rev Immunol. 2015; 15(10):615-29. DOI: 10.1038/nri3896. View

18.

Lomakin A, Lee K, Han S, Bui D, Davidson M, Mogilner A . Competition for actin between two distinct F-actin networks defines a bistable switch for cell polarization. Nat Cell Biol. 2015; 17(11):1435-45. PMC: 4628555. DOI: 10.1038/ncb3246. View

19.

Yan W, Han P, Zhou Z, Tu W, Liao J, Li P . Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness. Dig Dis Sci. 2014; 59(6):1213-21. DOI: 10.1007/s10620-013-3016-z. View

20.

Tsai J, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27(20):2192-206. PMC: 3814640. DOI: 10.1101/gad.225334.113. View